Internal Medicine, Hematology & Oncology · Bend, OR
NPI
1124081096
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
2500 NE Neff Rd
Bend, OR, 97701
Phone (541) 706-5800
Groups this clinician bills Medicare through
Medicare paid, 2024
$88K
1,671 services
Medicare patients, 2024
336
Average age 75
Drug cost, 2024
$6.8M
1,263 prescriptions
Company payments, 2025
$90
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew T Chen was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 603 times for 279 patients. In total Andrew T Chen billed 1,671 services in 19 codes, and Medicare paid $88K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-03.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 603 | 279 | $11.76 | $7,089 |
| 99214 Office E&M - Established | Facility | 564 | 277 | $65.59 | $37K |
| 99215 Office E&M - Established | Facility | 284 | 95 | $103.16 | $29K |
| 99204 Office E&M - New | Facility | 37 | 37 | $80.50 | $2,979 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 25 | 19 | $12.95 | $324 |
| 99212 Office E&M - Established | Facility | 22 | 19 | $26.39 | $581 |
| 38222 Other Organ Systems | Facility | 22 | 19 | $53.06 | $1,167 |
| 99205 Office E&M - New | Facility | 21 | 21 | $135.46 | $2,845 |
| 99213 Office E&M - Established | Facility | 18 | 17 | $45.27 | $815 |
| 99214 Office E&M - Established | Office | 18 | 14 | $91.13 | $1,640 |
By year: 2022 $2.4M for 141,598 services; 2023 $99K for 1,168 services; 2024 $88K for 1,671 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 2,430 | 1,194 | $2.95 | $7,175 |
| 85025 Blood Count | 1,664 | 584 | $7.63 | $13K |
| 80053 Clinical Chemistry | 1,336 | 540 | $10.39 | $14K |
| 84443 Clinical Chemistry | 360 | 265 | $16.55 | $5,957 |
| 82728 Clinical Chemistry | 326 | 123 | $13.38 | $4,362 |
| 80048 Clinical Chemistry | 276 | 249 | $8.35 | $2,303 |
| 83540 Clinical Chemistry | 268 | 105 | $6.34 | $1,700 |
| 84466 Clinical Chemistry | 267 | 104 | $12.50 | $3,337 |
| 80061 Clinical Chemistry | 203 | 167 | $13.12 | $2,663 |
| 83036 Blood Count | 181 | 145 | $9.46 | $1,711 |
Medicare prescription drug claims, 2024
In 2024, the drug Andrew T Chen prescribed most often to Medicare patients was Prednisone, with 97 prescriptions and refills. In total Andrew T Chen wrote 1,263 Medicare prescriptions that cost $6.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 97 | 130 | 20 | $449 |
| Abiraterone Acetate Generic | 79 | 79 | Under 11 | $9,491 |
| Acyclovir Generic | 79 | 169 | 30 | $1,575 |
| Hydroxyurea Generic | 73 | 168 | 18 | $1,966 |
| Pomalyst Pomalidomide | 62 | 62 | Under 11 | $1.4M |
| Calquence Acalabrutinib Maleate | 56 | 56 | Under 11 | $838K |
| Revlimid Lenalidomide | 54 | 54 | Under 11 | $877K |
| Ondansetron Hcl Generic | 46 | 46 | 22 | $326 |
| Dexamethasone Generic | 45 | 60 | 21 | $892 |
| Eliquis Apixaban | 45 | 72 | 17 | $41K |
| Lenalidomide Generic | 39 | 39 | Under 11 | $324K |
| Prochlorperazine Maleate Generic | 38 | 38 | 19 | $236 |
| Imatinib Mesylate Generic | 33 | 35 | Under 11 | $2,163 |
| Brukinsa Zanubrutinib | 31 | 31 | Under 11 | $443K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 27 | 56 | 13 | $148 |
Brand drugs: 415 claims; generic drugs: 848 claims; opioid claims: 43.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew T Chen $90 ($90 in general payments such as food, travel and fees) from 2 companies. The largest payer was Janssen Scientific Affairs, LLC with $90.
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC JNJ | 1 | $90 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.